Showing results (11-20 of 673) with videos related to
Sort By:
Pageof 68
Clinical Pharmacokinetics|January 1, 1995
Pharmacokinetics of antisense oligonucleotidesS Agrawal, J Temsamani, W Galbraith, et al.Biochemical Pharmacology|November 22, 1996
Modulation of oligonucleotide-induced immune stimulation by cyclodextrin analogsQ Zhao, J Temsamani, P L Iadarola, et al.Antisense & Nucleic Acid Drug Development|November 15, 1997
Pattern and kinetics of cytokine production following administration of phosphorothioate oligonucleotides in miceQ Zhao, J Temsamani, R Z Zhou, et al.Antisense Research and Development|January 1, 1994
Inhibition of in vitro transcription by oligodeoxynucleotidesJ Temsamani, V Metelev, A Levina, et al.Antisense Research and Development|January 1, 1994
Cellular uptake of oligodeoxynucleotide phosphorothioates and their analogsJ Temsamani, M Kubert, J Tang, et al.Biochemical Pharmacology|January 26, 1996
Effect of different chemically modified oligodeoxynucleotides on immune stimulationQ Zhao, J Temsamani, P L Iadarola, et al.Antisense & Nucleic Acid Drug Development|January 26, 1999
Cellular distribution of phosphorothioate oligonucleotide following intravenous administration in miceQ Zhao, R Zhou, J Temsamani, et al.Analytical Biochemistry|February 1, 1993
Comparison of in vitro transcriptions using various types of DNA templatesV Kohli, J TemsamaniBiotechnology and Applied Biochemistry|November 14, 1997
Antisense oligonucleotides: a new therapeutic approachJ Temsamani, P GuinotThe Journal of Biological Chemistry|October 4, 1996
The C-group heterogeneous nuclear ribonucleoprotein proteins bind to the 5' stem-loop of the U2 small nuclear ribonucleoprotein particleJ Temsamani, T PedersonPageof 68